The Use of Prebiotic and Probiotic Interventions for Treating Gastrointestinal and Psychosocial Health Symptoms in Cancer Patients and Survivors: A Systematic Review

Background: Cancer treatments can cause significant gastrointestinal (GI) health issues, and negatively affect patient’s psychosocial health and quality of life (QOL). Novel, integrative strategies using prebiotics and probiotics have been explored for treating adverse cancer treatment-related side...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Julie M. Deleemans MSc, Zen Gajtani BSc, Mohamad Baydoun RN, PhD, Raylene A. Reimer PhD, Katherine-Ann Piedalue BA, Linda E. Carlson PhD
Formato: article
Lenguaje:EN
Publicado: SAGE Publishing 2021
Materias:
Acceso en línea:https://doaj.org/article/8b02de382b43477e87c7516fd8df59cd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8b02de382b43477e87c7516fd8df59cd
record_format dspace
spelling oai:doaj.org-article:8b02de382b43477e87c7516fd8df59cd2021-12-02T01:03:37ZThe Use of Prebiotic and Probiotic Interventions for Treating Gastrointestinal and Psychosocial Health Symptoms in Cancer Patients and Survivors: A Systematic Review1552-695X10.1177/15347354211061733https://doaj.org/article/8b02de382b43477e87c7516fd8df59cd2021-11-01T00:00:00Zhttps://doi.org/10.1177/15347354211061733https://doaj.org/toc/1552-695XBackground: Cancer treatments can cause significant gastrointestinal (GI) health issues, and negatively affect patient’s psychosocial health and quality of life (QOL). Novel, integrative strategies using prebiotics and probiotics have been explored for treating adverse cancer treatment-related side effects. We evaluated the current literature for interventions using prebiotics or probiotics specifically to treat GI and psychosocial health issues in cancer patients and survivors. Methods: Five databases (PubMed, MEDLINE (Ovid), CINHAL, PsychINFO, Web of Science) were searched for studies with prebiotic or probiotic interventions where GI and/or psychosocial health outcomes were measured in adult cancer patients and survivors, and published before September 12th 2021. Results: Twelve studies (N = 974 participants) meeting the inclusion criteria were identified (randomized controlled trials [n = 10], single-group pre-post studies [n = 2]). Ten studies were conducted with patients on active cancer treatment, and 2 studies treated patients after anti-cancer therapies. Three studies used prebiotics, 7 studies used probiotics, and 2 studies used a combination therapy. The most commonly used probiotic strains were from the Lactobacillus genus. There was minimal evidence for prebiotics to improve GI or psychosocial health. Probiotics were associated with significant improvements in abdominal pain (n = 2), gas/bloating (n = 2), and especially diarrhea (n = 5), and with improvements in anxiety (n = 1), depression (n = 1), fatigue (n = 1), and QOL (n = 2). Conclusions: Studies specifically examining effects of prebiotics and probiotics on GI and psychosocial health outcomes are scarce. Probiotic intervention may improve some GI symptoms in cancer patients, and QOL in survivors. Controlled trials that consistently include GI and psychosocial health outcomes are needed.Julie M. Deleemans MScZen Gajtani BScMohamad Baydoun RN, PhDRaylene A. Reimer PhDKatherine-Ann Piedalue BALinda E. Carlson PhDSAGE PublishingarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENIntegrative Cancer Therapies, Vol 20 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Julie M. Deleemans MSc
Zen Gajtani BSc
Mohamad Baydoun RN, PhD
Raylene A. Reimer PhD
Katherine-Ann Piedalue BA
Linda E. Carlson PhD
The Use of Prebiotic and Probiotic Interventions for Treating Gastrointestinal and Psychosocial Health Symptoms in Cancer Patients and Survivors: A Systematic Review
description Background: Cancer treatments can cause significant gastrointestinal (GI) health issues, and negatively affect patient’s psychosocial health and quality of life (QOL). Novel, integrative strategies using prebiotics and probiotics have been explored for treating adverse cancer treatment-related side effects. We evaluated the current literature for interventions using prebiotics or probiotics specifically to treat GI and psychosocial health issues in cancer patients and survivors. Methods: Five databases (PubMed, MEDLINE (Ovid), CINHAL, PsychINFO, Web of Science) were searched for studies with prebiotic or probiotic interventions where GI and/or psychosocial health outcomes were measured in adult cancer patients and survivors, and published before September 12th 2021. Results: Twelve studies (N = 974 participants) meeting the inclusion criteria were identified (randomized controlled trials [n = 10], single-group pre-post studies [n = 2]). Ten studies were conducted with patients on active cancer treatment, and 2 studies treated patients after anti-cancer therapies. Three studies used prebiotics, 7 studies used probiotics, and 2 studies used a combination therapy. The most commonly used probiotic strains were from the Lactobacillus genus. There was minimal evidence for prebiotics to improve GI or psychosocial health. Probiotics were associated with significant improvements in abdominal pain (n = 2), gas/bloating (n = 2), and especially diarrhea (n = 5), and with improvements in anxiety (n = 1), depression (n = 1), fatigue (n = 1), and QOL (n = 2). Conclusions: Studies specifically examining effects of prebiotics and probiotics on GI and psychosocial health outcomes are scarce. Probiotic intervention may improve some GI symptoms in cancer patients, and QOL in survivors. Controlled trials that consistently include GI and psychosocial health outcomes are needed.
format article
author Julie M. Deleemans MSc
Zen Gajtani BSc
Mohamad Baydoun RN, PhD
Raylene A. Reimer PhD
Katherine-Ann Piedalue BA
Linda E. Carlson PhD
author_facet Julie M. Deleemans MSc
Zen Gajtani BSc
Mohamad Baydoun RN, PhD
Raylene A. Reimer PhD
Katherine-Ann Piedalue BA
Linda E. Carlson PhD
author_sort Julie M. Deleemans MSc
title The Use of Prebiotic and Probiotic Interventions for Treating Gastrointestinal and Psychosocial Health Symptoms in Cancer Patients and Survivors: A Systematic Review
title_short The Use of Prebiotic and Probiotic Interventions for Treating Gastrointestinal and Psychosocial Health Symptoms in Cancer Patients and Survivors: A Systematic Review
title_full The Use of Prebiotic and Probiotic Interventions for Treating Gastrointestinal and Psychosocial Health Symptoms in Cancer Patients and Survivors: A Systematic Review
title_fullStr The Use of Prebiotic and Probiotic Interventions for Treating Gastrointestinal and Psychosocial Health Symptoms in Cancer Patients and Survivors: A Systematic Review
title_full_unstemmed The Use of Prebiotic and Probiotic Interventions for Treating Gastrointestinal and Psychosocial Health Symptoms in Cancer Patients and Survivors: A Systematic Review
title_sort use of prebiotic and probiotic interventions for treating gastrointestinal and psychosocial health symptoms in cancer patients and survivors: a systematic review
publisher SAGE Publishing
publishDate 2021
url https://doaj.org/article/8b02de382b43477e87c7516fd8df59cd
work_keys_str_mv AT juliemdeleemansmsc theuseofprebioticandprobioticinterventionsfortreatinggastrointestinalandpsychosocialhealthsymptomsincancerpatientsandsurvivorsasystematicreview
AT zengajtanibsc theuseofprebioticandprobioticinterventionsfortreatinggastrointestinalandpsychosocialhealthsymptomsincancerpatientsandsurvivorsasystematicreview
AT mohamadbaydounrnphd theuseofprebioticandprobioticinterventionsfortreatinggastrointestinalandpsychosocialhealthsymptomsincancerpatientsandsurvivorsasystematicreview
AT rayleneareimerphd theuseofprebioticandprobioticinterventionsfortreatinggastrointestinalandpsychosocialhealthsymptomsincancerpatientsandsurvivorsasystematicreview
AT katherineannpiedalueba theuseofprebioticandprobioticinterventionsfortreatinggastrointestinalandpsychosocialhealthsymptomsincancerpatientsandsurvivorsasystematicreview
AT lindaecarlsonphd theuseofprebioticandprobioticinterventionsfortreatinggastrointestinalandpsychosocialhealthsymptomsincancerpatientsandsurvivorsasystematicreview
AT juliemdeleemansmsc useofprebioticandprobioticinterventionsfortreatinggastrointestinalandpsychosocialhealthsymptomsincancerpatientsandsurvivorsasystematicreview
AT zengajtanibsc useofprebioticandprobioticinterventionsfortreatinggastrointestinalandpsychosocialhealthsymptomsincancerpatientsandsurvivorsasystematicreview
AT mohamadbaydounrnphd useofprebioticandprobioticinterventionsfortreatinggastrointestinalandpsychosocialhealthsymptomsincancerpatientsandsurvivorsasystematicreview
AT rayleneareimerphd useofprebioticandprobioticinterventionsfortreatinggastrointestinalandpsychosocialhealthsymptomsincancerpatientsandsurvivorsasystematicreview
AT katherineannpiedalueba useofprebioticandprobioticinterventionsfortreatinggastrointestinalandpsychosocialhealthsymptomsincancerpatientsandsurvivorsasystematicreview
AT lindaecarlsonphd useofprebioticandprobioticinterventionsfortreatinggastrointestinalandpsychosocialhealthsymptomsincancerpatientsandsurvivorsasystematicreview
_version_ 1718403329990590464